vs
Side-by-side financial comparison of Andersons, Inc. (ANDE) and Enhabit, Inc. (EHAB). Click either name above to swap in a different company.
Andersons, Inc. is the larger business by last-quarter revenue ($329.5M vs $270.4M, roughly 1.2× Enhabit, Inc.). Andersons, Inc. runs the higher net margin — 20.5% vs -14.3%, a 34.8% gap on every dollar of revenue. On growth, Enhabit, Inc. posted the faster year-over-year revenue change (4.7% vs -2.4%). Enhabit, Inc. produced more free cash flow last quarter ($3.3M vs $-77.1M). Over the past eight quarters, Enhabit, Inc.'s revenue compounded faster (1.5% CAGR vs -1.8%).
The Andersons, Inc. is an American agribusiness established in 1947, that began as Andersons Truck Terminal (ATT) in the 1940s for the grain industry, headquartered in Maumee, Ohio. It is a diversified company rooted in agriculture that conducts business in the commodity merchandising, renewables, and plant nutrient sectors.
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
ANDE vs EHAB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $329.5M | $270.4M |
| Net Profit | $67.4M | $-38.7M |
| Gross Margin | 70.3% | — |
| Operating Margin | 26.6% | -12.3% |
| Net Margin | 20.5% | -14.3% |
| Revenue YoY | -2.4% | 4.7% |
| Net Profit YoY | 49.6% | 15.9% |
| EPS (diluted) | — | $-0.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $329.5M | $270.4M | ||
| Q3 25 | $295.8M | $263.6M | ||
| Q2 25 | $535.0M | $266.1M | ||
| Q1 25 | $370.8M | $259.9M | ||
| Q4 24 | $337.5M | $258.2M | ||
| Q3 24 | $231.9M | $253.6M | ||
| Q2 24 | $492.5M | $260.6M | ||
| Q1 24 | $341.4M | $262.4M |
| Q4 25 | $67.4M | $-38.7M | ||
| Q3 25 | $20.1M | $11.1M | ||
| Q2 25 | $7.9M | $5.2M | ||
| Q1 25 | $284.0K | $17.8M | ||
| Q4 24 | $45.1M | $-46.0M | ||
| Q3 24 | $27.4M | $-110.2M | ||
| Q2 24 | $36.0M | $-200.0K | ||
| Q1 24 | $5.6M | $200.0K |
| Q4 25 | 70.3% | — | ||
| Q3 25 | 57.8% | — | ||
| Q2 25 | 29.6% | — | ||
| Q1 25 | 41.2% | — | ||
| Q4 24 | 63.1% | — | ||
| Q3 24 | 76.4% | — | ||
| Q2 24 | 35.6% | — | ||
| Q1 24 | 37.6% | — |
| Q4 25 | 26.6% | -12.3% | ||
| Q3 25 | 8.7% | 6.4% | ||
| Q2 25 | 4.6% | 6.3% | ||
| Q1 25 | 0.9% | 6.1% | ||
| Q4 24 | 19.9% | -16.0% | ||
| Q3 24 | 26.8% | -38.6% | ||
| Q2 24 | 11.6% | 4.3% | ||
| Q1 24 | 4.1% | 4.9% |
| Q4 25 | 20.5% | -14.3% | ||
| Q3 25 | 6.8% | 4.2% | ||
| Q2 25 | 1.5% | 2.0% | ||
| Q1 25 | 0.1% | 6.8% | ||
| Q4 24 | 13.4% | -17.8% | ||
| Q3 24 | 11.8% | -43.5% | ||
| Q2 24 | 7.3% | -0.1% | ||
| Q1 24 | 1.6% | 0.1% |
| Q4 25 | — | $-0.76 | ||
| Q3 25 | $0.59 | $0.22 | ||
| Q2 25 | $0.23 | $0.10 | ||
| Q1 25 | $0.01 | $0.35 | ||
| Q4 24 | $1.31 | $-0.92 | ||
| Q3 24 | $0.80 | $-2.20 | ||
| Q2 24 | $1.05 | $0.00 | ||
| Q1 24 | $0.16 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $98.3M | $43.6M |
| Total DebtLower is stronger | $560.0M | $426.0M |
| Stockholders' EquityBook value | $1.2B | $534.0M |
| Total Assets | $3.7B | $1.2B |
| Debt / EquityLower = less leverage | 0.45× | 0.80× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $98.3M | $43.6M | ||
| Q3 25 | — | $56.9M | ||
| Q2 25 | — | $37.1M | ||
| Q1 25 | — | $39.5M | ||
| Q4 24 | $561.8M | $28.4M | ||
| Q3 24 | — | $45.7M | ||
| Q2 24 | — | $28.5M | ||
| Q1 24 | — | $36.5M |
| Q4 25 | $560.0M | $426.0M | ||
| Q3 25 | — | $441.5M | ||
| Q2 25 | — | $456.9M | ||
| Q1 25 | — | $467.3M | ||
| Q4 24 | $608.2M | $492.6M | ||
| Q3 24 | — | $502.9M | ||
| Q2 24 | — | $512.7M | ||
| Q1 24 | — | $526.7M |
| Q4 25 | $1.2B | $534.0M | ||
| Q3 25 | $1.2B | $566.8M | ||
| Q2 25 | $1.4B | $552.4M | ||
| Q1 25 | $1.4B | $543.2M | ||
| Q4 24 | $1.4B | $523.5M | ||
| Q3 24 | $1.3B | $566.1M | ||
| Q2 24 | $1.3B | $674.3M | ||
| Q1 24 | $1.3B | $672.3M |
| Q4 25 | $3.7B | $1.2B | ||
| Q3 25 | $3.3B | $1.2B | ||
| Q2 25 | $3.4B | $1.2B | ||
| Q1 25 | $3.8B | $1.2B | ||
| Q4 24 | $4.1B | $1.2B | ||
| Q3 24 | $3.4B | $1.3B | ||
| Q2 24 | $3.3B | $1.4B | ||
| Q1 24 | $3.3B | $1.4B |
| Q4 25 | 0.45× | 0.80× | ||
| Q3 25 | — | 0.78× | ||
| Q2 25 | — | 0.83× | ||
| Q1 25 | — | 0.86× | ||
| Q4 24 | 0.45× | 0.94× | ||
| Q3 24 | — | 0.89× | ||
| Q2 24 | — | 0.76× | ||
| Q1 24 | — | 0.78× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.2M | $4.4M |
| Free Cash FlowOCF − Capex | $-77.1M | $3.3M |
| FCF MarginFCF / Revenue | -23.4% | 1.2% |
| Capex IntensityCapex / Revenue | 21.5% | 0.4% |
| Cash ConversionOCF / Net Profit | -0.09× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-56.1M | $65.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.2M | $4.4M | ||
| Q3 25 | $233.9M | $37.8M | ||
| Q2 25 | $299.3M | $10.6M | ||
| Q1 25 | $-350.0M | $17.9M | ||
| Q4 24 | $268.8M | $-4.1M | ||
| Q3 24 | $-2.1M | $28.4M | ||
| Q2 24 | $304.4M | $9.6M | ||
| Q1 24 | $-239.6M | $17.3M |
| Q4 25 | $-77.1M | $3.3M | ||
| Q3 25 | $167.0M | $36.2M | ||
| Q2 25 | $250.5M | $8.7M | ||
| Q1 25 | $-396.6M | $17.6M | ||
| Q4 24 | $212.9M | $-4.7M | ||
| Q3 24 | $-40.0M | $27.7M | ||
| Q2 24 | $275.8M | $8.9M | ||
| Q1 24 | $-266.4M | $15.5M |
| Q4 25 | -23.4% | 1.2% | ||
| Q3 25 | 56.5% | 13.7% | ||
| Q2 25 | 46.8% | 3.3% | ||
| Q1 25 | -106.9% | 6.8% | ||
| Q4 24 | 63.1% | -1.8% | ||
| Q3 24 | -17.2% | 10.9% | ||
| Q2 24 | 56.0% | 3.4% | ||
| Q1 24 | -78.0% | 5.9% |
| Q4 25 | 21.5% | 0.4% | ||
| Q3 25 | 22.6% | 0.6% | ||
| Q2 25 | 9.1% | 0.7% | ||
| Q1 25 | 12.6% | 0.1% | ||
| Q4 24 | 16.6% | 0.2% | ||
| Q3 24 | 16.3% | 0.3% | ||
| Q2 24 | 5.8% | 0.3% | ||
| Q1 24 | 7.8% | 0.7% |
| Q4 25 | -0.09× | — | ||
| Q3 25 | 11.61× | 3.41× | ||
| Q2 25 | 38.10× | 2.04× | ||
| Q1 25 | -1232.46× | 1.01× | ||
| Q4 24 | 5.96× | — | ||
| Q3 24 | -0.08× | — | ||
| Q2 24 | 8.46× | — | ||
| Q1 24 | -42.94× | 86.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ANDE
| Specialty And Primary Nutrients | $137.1M | 42% |
| Premium Ingredients | $66.1M | 20% |
| Segment Reporting Reconciling Item Other | $63.2M | 19% |
| Other | $63.1M | 19% |
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
